NCT04926584View on ClinicalTrials.gov

Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Option

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 15, 2017

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2027

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

induction therapy

induction immuno-chemotherapy or immunotherapy prior to resection or definitive chemoradiotherapy

Trial Locations (1)

73730

RECRUITING

Klinikum Esslingen, Esslingen am Neckar

All Listed Sponsors
lead

Klinikum Esslingen

OTHER